enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Is 5 mg or 1 mg of Finasteride Better For Hair Loss? - AOL

   www.aol.com/5-mg-1-mg-finasteride-125800055.html

   BPH is a non-cancerous condition that can make urination difficult due to prostate enlargement pressing against the urethra. Nearly all men will eventually experience BPH at some point in their lives.

3. What are the Side Effects of Taking Finasteride for Hair Loss?

   www.aol.com/side-effects-taking-finasteride-hair...

   The findings of the study, published in 2003, found that the men in the finasteride group were actually nearly 30 percent less likely to get prostate cancer than men in the control group.

4. Finasteride - Wikipedia

   en.wikipedia.org/wiki/Finasteride

   In the prostate, this reduces prostate volume, which improves BPH and reduces the risk of prostate cancer. Finasteride reduces prostate volume by 20 to 30% in men with benign prostatic hyperplasia. [75] Inhibition of 5α-reductase also reduces epididymal weight, and decreases motility and normal morphology of spermatozoa in the epididymis. [76]

5. Dutasteride - Wikipedia

   en.wikipedia.org/wiki/Dutasteride

   A small risk of sexual side effects has been documented in men taking the drug during the first few months of therapy. [27] [28] The FDA added a black-box warning to dutasteride in 2011 describing an increased risk of high-grade prostate cancer in those who take the drug. [29]

6. Can Finasteride Lower Testosterone? (& Other Potential Side ...

   www.aol.com/finasteride-lower-testosterone-other...

   Research shows that taking 5 milligrams (mg) of finasteride a day for benign prostatic hyperplasia (BPH) — an enlarged prostate — can lead to a 15 to 25 percent increase in testosterone levels.

7. Medical uses of bicalutamide - Wikipedia

   en.wikipedia.org/wiki/Medical_uses_of_bicalutamide

   Bicalutamide is used primarily in the treatment of early and advanced prostate cancer. [1] It is approved at a dosage of 50 mg/day as a combination therapy with a gonadotropin-releasing hormone analogue (GnRH analogue) or orchiectomy (that is, surgical or medical castration) in the treatment of stage D2 metastatic prostate cancer (mPC), [2] [3] and as a monotherapy at a dosage of 150 mg/day ...